ABPI supports AMRC call to protect charity research

The AMRC and more than 30 top pharmaceutical and health tech companies have signed an open letter to the Prime Minister urging Government to provide financial support for medical research charities.

It is vital that our health research charities are supported through this challenging period if we are to achieve our long term ambitions for UK life sciences. Richard Torbett, ABPI Chief Executive

Supporting the AMRC's call, ABPI Chief Executive Richard Torbett said: 

“Medical research charities are a key strength of UK’s life sciences and advances in research depend on collaboration between industry, academia, the NHS and charities, with each playing a unique role.

“Our companies partner everyday with research charities who offer expert insights from their patient communities, which help to make sure that research and treatments maximise the benefits to patients.

“It is vital that our health research charities are supported through this challenging period if we are to achieve our long term ambitions for UK life sciences”.

Read more in the Financial Times. 

TAGS
  • AMRC

Last modified: 20 September 2023

Last reviewed: 20 September 2023

Related news

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.